MetaMETA

Business Snapshot

• Meta Platforms, Inc. Class A common stock (NASDAQ: META; USD), matched to SEC CIK 0001326801. This is a common stock, not an ETF, ADR, warrant, or unit.
• The supplied financials show substantial revenue and earnings, but also a recent step-up in investment spending and debt. No business-segment breakdown, valuation multiples, forward guidance, or analyst targets were provided.

Financial Trends

• Revenue: Latest quarter (June 30, 2026) was $60.801B, up $4.490B (+8.0%) from March 2026’s $56.311B and $9.559B (+18.7%) from September 2025’s $51.242B. The listed December 2025 figure is $200.966B and appears to cover a different period length; it is not directly comparable with quarterly figures, so sequential quarterly growth is the clearer signal.
• Operating margin: Fell to 30.88% in June from 40.62% in March (−9.74 percentage points) and 40.07% in September 2025 (−9.19 points). December 2025 was 41.44%. The latest period marks a sharp margin contraction after three reported periods around 40%–41%.
• Net margin and earnings: Net margin was 26.07% in June, down from 47.54% in March and 30.08% in December 2025, but above September 2025’s 5.29%. Net income fell $10.925B (−40.8%) from March’s $26.773B to June’s $15.848B; the supplied data do not explain the large period-to-period swings.
• Free cash flow: June FCF was $14.975B, up $1.746B (+13.2%) from March’s $13.229B, but down $16.303B (−52.1%) from September 2025’s $31.278B. December’s $46.109B is not directly comparable if it is an annual figure, as its magnitude suggests. Capital expenditures rose to $49.113B in June from $18.997B in March and $48.308B in September 2025; the reported investment burden remains high.
• Balance sheet: Total assets increased from $303.844B in September 2025 to $449.956B in June 2026 (+$146.112B, +48.1%); liabilities rose from $109.778B to $188.735B (+$78.957B, +71.9%), while equity grew from $194.066B to $261.221B (+$67.155B, +34.6%). Long-term debt climbed from $28.834B to $83.664B (+$54.830B); debt/equity rose from 0.15 to 0.32. Cash ended at $15.462B, below September’s $10.187B? No—up $5.275B versus September, but down $20.411B from December’s $35.873B peak.

Financial Health

• The latest quarter combines continued revenue growth and positive $14.975B FCF with materially lower operating and net margins than in the prior reported quarter. That mix supports underlying scale and cash generation, but the direction of margins warrants attention.
• Liquidity remains substantial by the supplied current ratio (2.23) and working capital ($69.096B), though the current ratio has eased from 2.60 in December 2025. Meanwhile, debt/equity has more than doubled from 0.15 in September 2025 to 0.32 in June 2026, and cash is down from its December level.
• The cash-flow figures are reported by period, but their large quarter-to-quarter swings and the December income statement/cash-flow magnitudes suggest different period lengths or cumulative reporting. Treat those cross-period comparisons cautiously; the payload does not clarify the reporting basis.

Insider Activity

• Sentiment is Neutral (−10) for June 30–September 28, 2026, with $74.82M in reported sales across 56 transactions and no reported purchases across 3 transactions. Net reported activity is −$74.82M.
• Recent Form 4 entries are sales by several executives, including Christopher Cox, Javier Olivan, and Aaron Anderson. Cox’s listed September sales include 20,000 shares at about $700.50 and 20,000 at about $725.02; Olivan also has multiple reported sales.
• This is a clear sell-skew in the supplied filings, but transaction data alone does not establish why the sales occurred or predict the share price.

Multi-Timeframe Technical Context

• Only daily indicator data is supplied; minute and intraday/hourly context cannot be assessed. The market is marked pre-market, so current price and session range may be provisional.
• The 200-bar daily series reports a move from $663.77 to $751.66 (+13.24%). Price is above the 12-, 26-, and 50-day EMAs ($706.30, $663.48, $636.08) and the 20-, 50-, and 200-day SMAs ($660.86, $615.75, $626.47): the broader daily trend is bullish.
• Momentum is strong but stretched: RSI(14) is 76.51 and RSI(21) 77.73, both in overbought territory. MACD (42.82) is above its signal (31.15), consistent with positive momentum.
• Price is near the upper Bollinger Band ($786.55; middle $660.86, lower $535.17). Daily ATR is $29.58, indicating sizable typical price movement. Reported current volume of 25.83M is above the 20-day average of 22.93M.

Bull / Bear Cases

• Short-term bull: Daily price is above all supplied moving averages, MACD remains above its signal, and reported volume exceeds its 20-day average. A sustained hold above nearby moving-average support could keep momentum pointed higher.
• Short-term bear: RSI readings above 76 and proximity to the upper Bollinger Band leave the move vulnerable to profit-taking or consolidation. The reported session range is unusually wide ($520.26–$779.82); because the market is pre-market and the range is exceptionally broad, verify the levels against live trading data before acting.
• Long-term bull: Revenue grew 18.7% from September 2025 to June 2026 on the comparable quarterly figures, and the latest reported quarter still produced positive operating income, net income, and FCF. Assets and equity also expanded over the four balance-sheet periods.
• Long-term bear: The latest operating margin fell nearly 10 points sequentially, FCF is below the September figure, and long-term debt has risen substantially as debt/equity moved from 0.15 to 0.32. Insider filings are sell-skewed, although their motivation is not provided. The supplied data lack guidance, segment trends, and valuation, limiting a complete forward fundamental assessment.

Key Levels & Triggers

• Upside reference: $779.82, the reported session high, followed by the $786.55 upper Bollinger Band. A sustained break and hold above these levels would strengthen the continuation case; the pre-market context makes confirmation important.
• Near-term support references: $706.30 (12-day EMA), then $663.48–$660.86 (26-day EMA and 20-day SMA). These are indicator references, not guaranteed support.
• Lower trend references: $636.08 (50-day EMA), $626.47 (200-day SMA), and $615.75 (50-day SMA). A decisive move below these would weaken the supplied daily uptrend structure.
• Fundamental triggers to monitor: whether operating margin stabilizes after the fall to 30.88%, whether FCF holds up alongside elevated capex, and whether debt growth moderates. The payload contains no upcoming event dates or company guidance.